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Short title Comorbid disease and ethnicity in emergency hospital admissions in east London 
Methodology 
Observational cohort study of outcomes in Black, Asian and 
Minority Ethnic (BAME) and non-BAME patients admitted to 
hospital following an emergency presentation 
Objectives / aims 
• To assess whether there is a difference in outcomes 
(death/organ support) between comorbidity and different 
ethnic backgrounds of patients with an emergency admission 
to hospital 
• To analyse differences in age, sex, and measure of socio-
economic deprivation in patients of Black, Asian and other 
ethnicities, compared to non-BAME ethnicity and to 







• Age 18 years or over 
• Emergency presentation to hospital 
• Admission to a Barts Health NHS Trust hospital between 
01/01/2013 and 31/12/2018 
Exclusion Criteria: 
• Unknown or undisclosed ethnicity 
• Obstetric admissions 
Statistical 
methodology and 
analysis (if applicable) 
• Prospectively defined observational study 
• Descriptive and comparative analyses of demographics, 
clinical characteristics and clinical outcomes between patients 
of different ethnicities using univariate and multivariable 
analysis 






The COVID-19 global pandemic has resulted in significant mortality and morbidity over a 
relatively short period of time (1). Greater impact of disease in severity and death on people 
from Black, Asian and Minority Ethnic (BAME) backgrounds has been reported (2-4). Using 
data from all acute hospitals within Barts Health NHS Trust, we observed that patients from 
Asian and Black backgrounds are more likely to die from COVID-19 infection despite 
controlling for age, other previously identified confounders and frailty (5). Furthermore, given 
their much younger age, COVID-19 patients of Asian and Black backgrounds suffered 
disproportionate rates of premature death. This association appeared to be underpinned by 
a combination of factors including socio-economic status (SES), pre-existing health conditions, 
biological risk factors such as D-dimers, environmental, and structural determinants of health. 
However, their relative contribution is unclear. 
 
Although COVID-19 has highlighted the effects of ethnic inequalities on health outcomes, 
these inequalities are not new. Health inequalities within and between ethnic minority groups 
have been widely documented (6). Ethnic minorities tend to have poorer health than majority 
ethnic groups. This has been clearly demonstrated in a range of conditions such as 
cardiovascular disease, diabetes, stroke, and hypertension (7). The relationship between 
ethnicity and health is complex as risk factors are likely to interact and are inextricably linked 
with wider social determinants. The important ethnic disparities unmasked during the COVID-
19 pandemic may represent features of poorer underlying health status within BAME 
patients.  
 
Whilst there is a body of evidence describing differences in race and ethnicity in the use of 
healthcare services, quality of health care and health outcomes, relatively few have been 
carried out in critically ill patients and the majority of studies have been conducted in 
healthcare systems where access and resource allocation differ (8). Prior studies have also 
been limited by sample size, inadequate risk adjustment and assessment of linked factors 
such as SES. A previous US observation study reported that minority ethnic patients presented 
with presenting with greater severity of illness to intensive care and had fewer elective 
admissions, however, there was no differences in mortality after adjustment for severity of 




Barts Health is the largest NHS Trust serving a majority (60%) BAME population within an area 
with some of the worst socio-economic deprivation and highest neighbourhood Index of 
Multiple Deprivation (IMD) scores. Understanding the ethnicity disparities unmasked by the 
COVID-19 pandemic is crucial in determining underlying causes and identifying population 
specific interventions. 
 
This aim of this comparative study is to determine in a cohort of non-COVID emergency 
hospital admissions within the same representative population in east London, whether there 
is a difference in outcomes in patients of different ethnicities. It will test the hypothesis that 
patients of Black, Asian and other ethnicities have poorer outcomes defined using mortality 
and length of stay. Data generated has the potential to influence and shape relevant policy 
and practice to improve health outcomes in BAME communities. 
  
2. Study objectives 
 
2.1. Primary objective 
 
This study aims to assess whether there is an comorbidity, age and sex adjusted difference in 
outcomes in different ethnicities of patients admitted with an emergency presentation to 
hospitals within Barts Health NHS Trust. 
 
The study will test the hypothesis that there is an association between health outcomes 
defined using mortality and length of stay; and ethnicity; with patients of Black, Asian and 
other ethnicities having poorer outcomes as compared to patients of White ethnicity. 
 
2.2. Secondary objective 
 
We will examine the strength and nature of relationship between ethnic background and 
outcome in multivariable age, sex, co-morbidity, and frailty adjusted multivariable survival 
analysis. 
 
We hypothesise that BAME background patients may be disproportionately younger, have 
greater baseline co-morbidity and have greater socio-economic deprivation than non-BAME 
counterparts and we will document these differences and explore their effects on outcome 
in the analysis. 
 
2.3. Primary endpoint 
 
The primary endpoint will be 30-day mortality from time of first hospital admission with an 
emergency presentation. 
 
2.4. Secondary endpoints 
 
The secondary endpoints will be: 
• 1-year mortality 
• Discharged from hospital alive 
o Discharge destination 
• Length of stay in hospital  
3. Study population 
 
3.1. Inclusion criteria 
 
• Age 18 years or over 
• Emergency presentation to hospital 
• Admission to a Barts Health NHS Trust hospital between 01/01/2013 and 31/12/2018 
 
3.2. Exclusion criteria 
 
• Unknown or undisclosed ethnicity status 
• Obstetric admission 
 
4. Study design 
 
This is a prospectively defined observational cohort study utilising data from the Barts Health 
Electronic Patient Record (EPR) system. 
 
Data analysis will include, but not limited to: 
• A comparison of clinical characteristics between patients of different ethnicities. 
• A comparison of age at presentation and age-standardised mortality between patients of 
different ethnicities. 
• An assessment of clinical outcomes following an acute hospital admission. 
• An assessment of ethnicity as a predictor of outcome using univariate and multivariable 
analysis. This will include adjustment for potential confounders such as co-morbidity and 
postcode of residence/Index of Multiple Deprivation (IMD). 
 
5. Study procedures 
 
Consent 
This study involves the aggregated analysis of an anonymised dataset collated by members 
of the direct care team and should not require REC review or consent. 
 
Data collection 
Hospital Cerner Millennium Data Warehouse records will then be used to obtain clinical, 
demographic and blood results by members of the clinical team participating in this study.  
 
No patient notes will be required or examined.  This data will be recorded in a Microsoft Excel 
Database maintained under password protection on the secure Trust internal network. After 
results for each patient have been collated by a member of the direct clinical care team. Once 
collation of the database is complete an anonymised database lacking all patient identifiable 
details will be analysed by the investigators. For analysis see statistical details below. 
 
Permissions 
Procedures for data collection and study protocols have been approved by HRA under IRAS 
ID 273546, an amendment has been made for this study as a secondary analysis. 
 
6. Statistical considerations 
 
The Chief Investigator takes responsibility for the statistics and statistical oversight for this 
study.  
 
6.1. Sample size  
 
The cohort to be analysed in this study comprises patients admitted critical care at the Royal 
London Hospital between 1st January 2013 and 31st December 2018. 
 
This will be a retrospective review of routinely collected data and we anticipate that around 
100,000 patients will meet our inclusion criteria, but the final sample size will be dictated by 
the data available. 
 
6.2. Method of analysis  
 
Software 
Statistical analyses will be performed using R: A language and environment for statistical 
computing (R Core Team (2020). R Foundation for Statistical Computing, Vienna, Austria. 
http://www.R-project.org/).  
 





The ethnic categories to be used will be the 16+1 ethnic data categories defined in the 2001 
census which form national mandatory standard for the collection and analysis of ethnicity in 







C Any other White background 
Mixed 
D White and Black Caribbean 
E White and Black African 
F White and Asian 
G Any other mixed background 




L Any other Asian background 
Black or Black British 
M Caribbean 
N African 
P Any other Black background 
Other Ethnic Groups 
R Chinese 
S Any other ethnic group 
- 
Z Not stated (excluded from this analysis) 
 
In order to preserve statistical power to detect differences between groups primary analysis 
will be performed between ethnicity as defined by the 5-high level groups White, Mixed, 
Asian or Asian British, Black or Black British and Other. 
 
Death will be defined by the presence of a date of death or discharge destination “patient 
died” in hospital electronic records (these are synchronised with NHS spine to capture out of 
hospital deaths). 
 
Emergency admissions will be categorised by medical or surgical. 
 
Smoking 
History of tobacco use will be defined by presence of the WHO ICD-10 codes F17·1-F17·2, 
Z72·0, Z87·8, Z71·6 and T65·2. 
 
Ischaemic heart disease 
Ischaemic heart disease (IHD) will be defined by the presence of the ICD-10 codes I23·4-
I23·5, I24, I24·8-I24·9, I25, I25·3-I25·6, I25·8-I25·9, I34·1, I46·1, I51·8-I51·9, and I52. 
 
End stage Renal disease 
End stage Renal disease (ESRD) will be defined by the presence of the ICD10 codes I77·0, 
N16·5, N18·5, T82·4, T86·1, Y60·2, Y61·2, and Y62·2, Y84·1, Z49·0-Z49·2, Z94·0, Z99·2. 
 
Comorbidity 
Diagnosis of co-morbidities and assignment of Charlson Comorbidity Index will be based on 
mapping from ICD-10 coding from previous admissions. Diagnosis of Hypertension will be 
based on mapping ICD-10 codes to the Elixhauser comorbidity index. 
 
Hospital frailty risk score 
Hospital frailty risk score will be calculated from mapping ICD-10 coding of hospital 
attendances.  
 
Acute Kidney injury 
Acute kidney injury (AKI) within first 7 days of admission will be defined using the KDIGO 
2012 creatinine criteria either a 1·5-fold rise over baseline within 7 days or 26 µmol rise 
within 48 hours. Baseline creatinine will be the median value in the 7 to 365 days before 
hospitalisation. Absent baseline creatinine will be determined based on an eGFR of 75 
ml/min/1·72m2 using the CKDepi formula or the admission value whichever is lower. 
 
Chronic kidney disease 
History of chronic kidney disease (CKD) using baseline eGFR will be calculated using last 
creatinine value available from results earlier than 7 days before hospitalisation. CKD will 
defined as baseline eGFR below 60 ml/min/1·72m2. 
 
Index of Multiple Deprivation 
Index of Multiple Deprivation will be defined from patient home address postcode using UK 
government statistics https://www.gov.uk/government/statistics/english-indices-of-




Clinical outcomes for the whole cohort will be analysed and also stratified by ethnicity. 
Univariate and multivariable analyses will subsequently be used to investigate predictors of 
outcome for each ethnicity. 
 
All continuous data will be expressed as median and interquartile range (IQRs) and categorical 
data as proportion. For continuous data, we will compare the mean difference between 
groups by ANOVA or Kruskal-Wallis test. For dichotomous data, we will use Pearson Chi-
square test or Fisher exact test (if expected number less than 5).  The log-rank and Wilcoxon 
test will be used for survival time comparisons between groups.  
 
Sample Table 1 
 
 Black Asian Mixed Other  White P value 
Age        
Sex       
IMD quintile       
Smoking       
BMI       
Comorbidity       
Obesity       
IHD       
DM       
HTN       
CKD       
Charlson co-morbidity index       
Frailty       
Rockwood frailty score       
Hospital frailty risk score       
AKI       
Length of stay       
Death       
In-hospital       
30 day       
90 day       
Discharge destination       
Care home or equivalent       
Health-related institution       
Usual place of residence       
Hospice or equivalent       
Temporary place of residence       
 
Primary and Secondary Endpoint Analysis 
 
Primary endpoint will be 30-day mortality between ethnic groupings adjusted for patient age 
and sex. A restricted cubic spline model will be used to account for non-linear effects of age. 
Mortality comparison will be analysed using Cox-proportional Hazard analysis censored at 30 
days or time of maximal follow-up or logistic regression analysis if non-proportionality 
between ethnic groups and risk of death over time is evident. 
 
Age and sex adjusted incidence of secondary endpoints will be assessed using logistic 
regression on Cox hazard models as appropriate. 
 
Hospital site will be included in all models as a fixed effect variable to account for potential 




If available, the following variables will be collected and considered in multi-variable analysis 






• Smoking status 
• Clinical frailty Scale at admission if recorded 
• Co-morbidities based on ICD-10 coding for current and previous admission based on 
established mapped to Charlson co-morbidty index and Elixhauser Index 




• Index of Multiple deprivation (IMD) 
 
Interaction with IMD 
 




Focusing on patients with an address in the boroughs of Tower Hamlets, Waltham Forest, and 
Newham, we will compare distribution of admissions by age across ethnic groups with 
distribution of people by age across ethnic groups within these boroughs. In order to account 
for differences in age structure between ethnic groups, we will calculate comparative 





To assess the effect of including patients living outside the Barts Health NHS Trust catchment 
area, the primary survival outcomes analysis will be repeated using a subset of patients 
residing within Tower Hamlets, Newham, and Waltham Forest only. Multivariable analysis 
will be repeated using aggregate measures of frailty in place of specific co-morbidities listed 
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